StoryOther

Insilico reports H1 2026 revenue of $106 million with 287% year-over-year growth

Insilico Medicine

Insilico reported approximately $106 million in revenue for the first half of 2026, representing 287% year-over-year growth. The company achieved profitability with over $51 million in adjusted net profit, demonstrating the commercial viability of its AI-driven platform.

Read the original · Press

More on Insilico Medicine

Primer